{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:49:54Z","timestamp":1792622994807,"version":"4.5.0"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000},"content-version":"vor","delay-in-days":1505,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T00:00:00Z","timestamp":1585785600000},"content-version":"vor","delay-in-days":63,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["asbmr.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,12,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Recent studies suggest that the RANK\/RANKL system impacts muscle function and\/or mass. In the pivotal placebo-controlled fracture trial of the RANKL inhibitor denosumab in women with postmenopausal osteoporosis, treatment was associated with a lower incidence of non-fracture-related falls (p = 0.02). This ad hoc exploratory analysis pooled data from five placebo-controlled trials of denosumab to determine consistency across trials, if any, of the reduction of fall incidence. The analysis included trials in women with postmenopausal osteoporosis and low bone mass, men with osteoporosis, women receiving adjuvant aromatase inhibitors for breast cancer, and men receiving androgen deprivation therapy for prostate cancer. The analysis was stratified by trial, and only included data from the placebo-controlled period of each trial. A time-to-event analysis of first fall and exposure-adjusted subject incidence rates of falls were analyzed. Falls were reported and captured as adverse events. The analysis comprised 10,036 individuals; 5030 received denosumab 60\u2009mg subcutaneously once every 6\u2009months for 12 to 36\u2009months and 5006 received placebo. Kaplan\u2013Meier estimates showed an occurrence of falls in 6.5% of subjects in the placebo group compared with 5.2% of subjects in the denosumab group (hazard ratio = 0.79; 95% confidence interval 0.66\u20130.93; p = 0.0061). Heterogeneity in study designs did not permit overall assessment of association with fracture outcomes. In conclusion, denosumab may reduce the risk of falls in addition to its established fracture risk reduction by reducing bone resorption and increasing bone mass. These observations require further exploration and confirmation in studies with muscle function or falls as the primary outcome. \u00a9 2020 The Authors. Journal of Bone and Mineral Research published by American Society for Bone and Mineral Research..<\/jats:p>","DOI":"10.1002\/jbmr.3972","type":"journal-article","created":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T11:49:25Z","timestamp":1580384965000},"page":"1014-1021","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["A Pooled Analysis of Fall Incidence From Placebo-Controlled Trials of Denosumab"],"prefix":"10.1093","volume":"35","author":[{"given":"Pojchong","family":"Chotiyarnwong","sequence":"first","affiliation":[{"name":"Academic Unit of Bone Metabolism, Department of Oncology and Metabolism, The Mellanby Centre for Bone Research, The Centre for Integrated Research in Musculoskeletal Ageing University of Sheffield Sheffield UK"},{"name":"Department of Orthopaedic Surgery, Faculty of Medicine, Siriraj Hospital Mahidol University Bangkok Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0177-8140","authenticated-orcid":false,"given":"Eugene","family":"McCloskey","sequence":"additional","affiliation":[{"name":"Academic Unit of Bone Metabolism, Department of Oncology and Metabolism, The Mellanby Centre for Bone Research, The Centre for Integrated Research in Musculoskeletal Ageing University of Sheffield Sheffield UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Eastell","sequence":"additional","affiliation":[{"name":"Academic Unit of Bone Metabolism, Department of Oncology and Metabolism, The Mellanby Centre for Bone Research, The Centre for Integrated Research in Musculoskeletal Ageing University of Sheffield Sheffield UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R","family":"McClung","sequence":"additional","affiliation":[{"name":"Oregon Osteoporosis Center Portland OR USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelien","family":"Gielen","sequence":"additional","affiliation":[{"name":"Center for Metabolic Bone Diseases University Hospitals Leuven, and Department of Chronic Diseases, Metabolism, and Aging, (CHROMETA), KU Leuven Leuven Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Gostage","sequence":"additional","affiliation":[{"name":"Academic Unit of Bone Metabolism, Department of Oncology and Metabolism, The Mellanby Centre for Bone Research, The Centre for Integrated Research in Musculoskeletal Ageing University of Sheffield Sheffield UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"McDermott","sequence":"additional","affiliation":[{"name":"Amgen Inc. Thousand Oaks CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arkadi","family":"Chines","sequence":"additional","affiliation":[{"name":"Amgen Inc. Thousand Oaks CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Huang","sequence":"additional","affiliation":[{"name":"Amgen Inc. Thousand Oaks CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8808-260X","authenticated-orcid":false,"given":"Steven R","family":"Cummings","sequence":"additional","affiliation":[{"name":"San Francisco Coordinating Center, California Pacific Medical Center (CPMC) Research Institute and the University of California San Francisco CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,1,30]]},"reference":[{"issue":"3","key":"2024031418591762500_jbmr3972-bib-0001","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jocd.2012.07.002","article-title":"Increasing incidence of hip fracture in Chiang Mai, Thailand","volume":"16","author":"Wongtriratanachai","year":"2013","journal-title":"J Clin Densitom."},{"key":"2024031418591762500_jbmr3972-bib-0002","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1186\/s12913-016-1719-5","article-title":"Experiences of general practitioners, home care nurses, physiotherapists and seniors involved in a multidisciplinary home-based fall prevention programme: a mixed method study","volume":"16","author":"Amacher","year":"2016","journal-title":"BMC Health Serv Res."},{"issue":"16","key":"2024031418591762500_jbmr3972-bib-0003","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1001\/jama.2017.21962","article-title":"Interventions to prevent falls in older adults: updated evidence report and systematic review for the US Preventive Services Task Force","volume":"319","author":"Guirguis-Blake","year":"2018","journal-title":"JAMA."},{"key":"2024031418591762500_jbmr3972-bib-0004","first-page":"CD012221","article-title":"Multifactorial and multiple component interventions for preventing falls in older people living in the community","volume":"7","author":"Hopewell","year":"2018","journal-title":"Cochrane Database Syst Rev."},{"key":"2024031418591762500_jbmr3972-bib-0005","first-page":"CD005465","article-title":"Interventions for preventing falls in older people in care facilities and hospitals","volume":"9","author":"Cameron","year":"2018","journal-title":"Cochrane Database Syst Rev."},{"issue":"17","key":"2024031418591762500_jbmr3972-bib-0006","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1001\/jama.2017.15006","article-title":"Comparisons of interventions for preventing falls in older adults: a systematic review and meta-analysis","volume":"318","author":"Tricco","year":"2017","journal-title":"JAMA."},{"issue":"3","key":"2024031418591762500_jbmr3972-bib-0007","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1331\/JAPhA.2009.09044","article-title":"Medication interventions for fall prevention in the older adult","volume":"49","author":"Cooper","year":"2009","journal-title":"J Am Pharm Assoc (2003)."},{"issue":"7","key":"2024031418591762500_jbmr3972-bib-0008","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/j.1532-5415.2010.02949.x","article-title":"Vitamin D treatment for the prevention of falls in older adults: systematic review and meta-analysis","volume":"58","author":"Kalyani","year":"2010","journal-title":"J Am Geriatr Soc."},{"issue":"9","key":"2024031418591762500_jbmr3972-bib-0009","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00132-017-3446-y","article-title":"The effect of vitamin D and calcium supplementation on falls in older adults: a systematic review and meta-analysis","volume":"46","author":"Wu","year":"2017","journal-title":"Orthopade."},{"issue":"8","key":"2024031418591762500_jbmr3972-bib-0010","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med."},{"issue":"2","key":"2024031418591762500_jbmr3972-bib-0011","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell."},{"issue":"1","key":"2024031418591762500_jbmr3972-bib-0012","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40478-018-0533-1","article-title":"Genetic deletion of muscle RANK or selective inhibition of RANKL is not as effective as full-length OPG-fc in mitigating muscular dystrophy","volume":"6","author":"Dufresne","year":"2018","journal-title":"Acta Neuropathol Commun."},{"issue":"2","key":"2024031418591762500_jbmr3972-bib-0013","first-page":"e13231","article-title":"Physiological role of receptor activator nuclear factor-kB (RANK) in denervation-induced muscle atrophy and dysfunction","volume":"3","author":"Dufresne","year":"2016","journal-title":"Receptors Clin Investig."},{"key":"2024031418591762500_jbmr3972-bib-0014","first-page":"S10","article-title":"Denosumab improves muscle function and glucose homeostasis","volume":"102","author":"Bonnet","year":"2018","journal-title":"Calcif Tissue Int."},{"key":"2024031418591762500_jbmr3972-bib-0015","doi-asserted-by":"crossref","first-page":"66","DOI":"10.12659\/AJCR.882771","article-title":"Treatment of facioscapulohumeral muscular dystrophy with denosumab","volume":"13","author":"Lefkowitz","year":"2012","journal-title":"Am J Case Rep."},{"issue":"5","key":"2024031418591762500_jbmr3972-bib-0016","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s11914-018-0468-2","article-title":"Targeting the muscle-bone unit: filling two needs with one deed in the treatment of Duchenne muscular dystrophy","volume":"16","author":"Boulanger Piette","year":"2018","journal-title":"Curr Osteoporos Rep."},{"issue":"6","key":"2024031418591762500_jbmr3972-bib-0017","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1210\/jc.2007-2814","article-title":"Effects of denosumab on bone mineral density and bone turnover in postmenopausal women","volume":"93","author":"Bone","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2024031418591762500_jbmr3972-bib-0018","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1210\/jc.2014-4079","article-title":"A 24-month study evaluating the efficacy and safety of denosumab for the treatment of men with low bone mineral density: results from the ADAMO trial","volume":"100","author":"Langdahl","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"issue":"30","key":"2024031418591762500_jbmr3972-bib-0019","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1200\/JCO.2008.16.3832","article-title":"Randomized trial of denosumab in patients receiving adjuvant aromatase inhibitors for nonmetastatic breast cancer","volume":"26","author":"Ellis","year":"2008","journal-title":"J Clin Oncol."},{"issue":"8","key":"2024031418591762500_jbmr3972-bib-0020","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJMoa0809003","article-title":"Denosumab in men receiving androgen-deprivation therapy for prostate cancer","volume":"361","author":"Smith","year":"2009","journal-title":"N Engl J Med."},{"issue":"1","key":"2024031418591762500_jbmr3972-bib-0021","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00198-015-3386-5","article-title":"Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation","volume":"27","author":"Weaver","year":"2016","journal-title":"Osteoporos Int."},{"issue":"5","key":"2024031418591762500_jbmr3972-bib-0022","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/00913847.1986.11709075","article-title":"Exercise compliance: a new view for public health","volume":"14","author":"Dishman","year":"1986","journal-title":"Phys Sportsmed."},{"issue":"11","key":"2024031418591762500_jbmr3972-bib-0023","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/ptj\/73.11.771","article-title":"Correlates of exercise compliance in physical therapy","volume":"73","author":"Sluijs","year":"1993","journal-title":"Phys Ther."},{"key":"2024031418591762500_jbmr3972-bib-0024","doi-asserted-by":"crossref","first-page":"b3692","DOI":"10.1136\/bmj.b3692","article-title":"Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials","volume":"339","author":"Bischoff-Ferrari","year":"2009","journal-title":"BMJ."},{"issue":"15","key":"2024031418591762500_jbmr3972-bib-0025","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1001\/jama.2018.4023","article-title":"Preventing fractures and falls: a limited role for calcium and vitamin D supplements?","volume":"319","author":"Bischoff-Ferrari","year":"2018","journal-title":"JAMA."},{"issue":"5","key":"2024031418591762500_jbmr3972-bib-0026","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S8756-3282(99)00214-8","article-title":"Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues","volume":"25","author":"Kartsogiannis","year":"1999","journal-title":"Bone."},{"issue":"4","key":"2024031418591762500_jbmr3972-bib-0027","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.ajpath.2015.01.006","article-title":"Osteoprotegerin protects against muscular dystrophy","volume":"185","author":"Dufresne","year":"2015","journal-title":"Am J Pathol."},{"issue":"8","key":"2024031418591762500_jbmr3972-bib-0028","doi-asserted-by":"crossref","first-page":"C663","DOI":"10.1152\/ajpcell.00285.2015","article-title":"Muscle RANK is a key regulator of Ca2+ storage, SERCA activity, and function of fast-twitch skeletal muscles","volume":"310","author":"Dufresne","year":"2016","journal-title":"Am J Physiol Cell Physiol."},{"key":"2024031418591762500_jbmr3972-bib-0029","first-page":"S12","article-title":"Overexpression of human RANKL decreases skeletal muscle function and engenders insulin resistance","volume":"100","author":"Bonnet","year":"2017","journal-title":"Calcif Tissue Int."},{"key":"2024031418591762500_jbmr3972-bib-0030","author":"Rolland","year":"2016"},{"issue":"4","key":"2024031418591762500_jbmr3972-bib-0031","first-page":"62","article-title":"Muscle-bone crosstalk: emerging opportunities for novel therapeutic approaches to treat musculoskeletal pathologies","volume":"5","author":"Maurel","year":"2017","journal-title":"Biomedicine."},{"issue":"8","key":"2024031418591762500_jbmr3972-bib-0032","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s00198-018-4570-1","article-title":"Impact of muscle atrophy on bone metabolism and bone strength: implications for muscle-bone crosstalk with aging and disuse","volume":"29","author":"Bettis","year":"2018","journal-title":"Osteoporos Int."},{"issue":"7","key":"2024031418591762500_jbmr3972-bib-0033","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/GME.0b013e31827cabca","article-title":"Concomitant increase in muscle strength and bone mineral density with decreasing IL-6 levels after combination therapy with alendronate and calcitriol in postmenopausal women","volume":"20","author":"Park","year":"2013","journal-title":"Menopause."},{"issue":"2","key":"2024031418591762500_jbmr3972-bib-0034","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1055\/s-0031-1296175","article-title":"Potency of a combined alfacalcidol-alendronate therapy to reduce the risk of falls and fractures in elderly patients with glucocorticoid-induced osteoporosis","volume":"61","author":"Ringe","year":"2011","journal-title":"Arzneimittelforschung"},{"issue":"1","key":"2024031418591762500_jbmr3972-bib-0035","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1055\/s-0031-1296166","article-title":"Risk reduction of falls and fractures, reduction of back pain and safety in elderly high risk patients receiving combined therapy with alfacalcidol and alendronate: a prospective study","volume":"61","author":"Schacht","year":"2011","journal-title":"Arzneimittelforschung."},{"issue":"1","key":"2024031418591762500_jbmr3972-bib-0036","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0735-1097(01)01327-4","article-title":"Lower standing systolic blood pressure as a predictor of falls in the elderly: a community-based prospective study","volume":"38","author":"Kario","year":"2001","journal-title":"J Am Coll Cardiol."},{"issue":"6 Pt 1","key":"2024031418591762500_jbmr3972-bib-0037","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1161\/01.HYP.19.6.508","article-title":"Orthostatic hypotension in older adults. The Cardiovascular Health Study. CHS Collaborative Research Group","volume":"19","author":"Rutan","year":"1992","journal-title":"Hypertension."},{"issue":"5","key":"2024031418591762500_jbmr3972-bib-0038","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/MOO.0b013e32833ce5a6","article-title":"Geriatric vestibulopathy assessment and management","volume":"18","author":"Furman","year":"2010","journal-title":"Curr Opin Otolaryngol Head Neck Surg."},{"key":"2024031418591762500_jbmr3972-bib-0039","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11556-013-0134-8","article-title":"Physical consequences of falls in the elderly: a literature review from 1995 to 2010","volume":"11","author":"Terroso","year":"2014","journal-title":"Eur Rev Aging Phys Act."}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.3972","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jbmr.3972","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jbmr.3972","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/35\/6\/1014\/55453485\/jbmr3972.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/35\/6\/1014\/55453485\/jbmr3972.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T15:04:27Z","timestamp":1710428667000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/35\/6\/1014\/7516466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,30]]},"references-count":39,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,1,30]]},"published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.3972","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737290793.793570632","asserted-by":"object"}]},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,12,1]]},"published":{"date-parts":[[2020,1,30]]},"assertion":[{"value":"2019-07-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-02","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}